CCI approves acquisition of equity in Continuum Green Energy by Chubu Electric Power (See 'Corp Brief') IPR - Goodwill of partnership is partnership asset, and only partners have right to property of firm subject to contract: HC (See 'Legal Desk') CCI nod for acquisition of majority shares in Volkswagen subsidiary by Bain Capital Investors (See 'Corp Brief') CCI fine with acquisition of 100% shareholding of FMC India by Crystal Crop Protection (See 'Corp Brief') IPR - Cable operator's licence did not extend to hotel's commercial use, as definition of subscriber under Cable Television Networks (Regulation) Act prohibits further transmission to any other person: HC (See 'Legal Desk') CCI okays acquisition of equity in IndiaFirst Life Insurance by BNP Paribas (See 'Corp Brief') HD Kumaraswamy launches Impact Report of MHI Industry Accelerator (See 'Corp Brief') A&C - Orders where Courts of Record refrain from exercising contempt jurisdiction are not appealable under Section 19 of CC Act: HC (See 'Legal Desk') NIFT Students make a Mark at WorldSkills Shanghai 2026 with Two Silver Medals (See 'Corp Brief') UIDAI unveils 5 new initiatives at Aadhaar Samvaad Kolkata (See 'Corp Brief') Ministry of Tribal Affairs and IGNCA sign MoU for Promotion of Tribal Cultural Heritage (See 'Corp Brief') IBC - Regulatory fee introduced by Insolvency and Bankruptcy Board of India with effect from Oct 01, 2022, is neither ultra vires IBC nor violative to Art 14 of Constitution: HC (See 'Legal Desk') Shekhawat felicitates 20 Award-Winning Artists at National Exhibition of Arts (See 'Corp Brief') CAQM approves revised GRAP Schedule; Tightens Measures for Vehicles (See 'Corp Brief') Civil Aviation Minister curtain-raises Routes Asia (See 'Corp Brief') IPR - If websites prima facie bear hallmarks of rogue websites and are predominantly engaged in facilitating copyright infringement, court can grant ad-interim blocking and anti-infringement relief against them: HC (See 'Legal Desk') Govt hands over first PRAMAAN certificates to AP and a Bamboo Farmer from Odisha (See 'Corp Brief') NITI Aayog organises National Workshop on 'Viksit Panchayat' (See 'Corp Brief') A&C - Validity of unilateral appointment of sole Arbitrator in arbitrations commenced before Oct 23, 2015, must be tested under pre-amendment regime: HC (See 'Legal Desk') India showcases Forest and Landscape Restoration Initiatives at COFO 28 in Rome (See 'Corp Brief') Railways approves Rs 122 Crore for 6 km Barbil-Bolanikhadan Doubling Project (See 'Corp Brief') Yadav reviews Delhi's Air Pollution Mitigation Plan with Delhi CM (See 'Corp Brief') IPR - Registered proprietor of well-known trademark is entitled to immediate ex-parte injunctive relief against anonymous entities operating rogue websites with masked identities: HC (See 'Legal Desk') Chouhan calls for Scientific Monitoring for Rabi Season 2026 (See 'Corp Brief') MoS pitches for wider Govt-Industry and Start-up collaboration in Space Sector (See 'Corp Brief') IPR - If both trademark infringement and passing off causes of action arise in Kerala, plaintiff cannot invoke Sec 134(2) of Trade Marks Act to club claims and force small Kerala-based defendant to litigate in Mumbai: HC (See 'Legal Desk') PM-MKSSY transforming Risk Management for India's Aquaculture Farmers (See 'Corp Brief') Nadda reviews Progress of Lady Hardinge Medical College (See 'Corp Brief') A&C - For awarding damages u/s 73 of Contract Act, proof of loss or injury is sine qua non, and Hudson Formula is no substitute for proof of damages: HC (See 'Legal Desk') CBN Rajasthan Unit seizes nearly four tonnes of contrabands (See 'Corp Brief') Ministry of Tourism exchanges MoUs with industry partners to strengthen tourism promotion (See 'Corp Brief') India moving from Defence Importer to Trusted Global Defence Supplier: RM (See 'Corp Brief') A & C - High Court erred in holding that petitions filed u/s 34 of the Act were barred by limitation, considering that applications were filed well within statutory limitation period: SC (See 'Legal Desk') NZP to celebrate Wildlife Week 2026 from 2nd - 8th October 2026 (See 'Corp Brief') HM launches various initiatives related to women empowerment in Kollam (See 'Corp Brief') Medical colleges rise from 387 to over 800: Patel (See 'Corp Brief') TradeMarks - When special law like Trade Marks Act restricts institution of suits to courts not inferior to District Judge, it remains entirely consistent with Commercial Courts Act, provided High Courts designate District Judges as commercial courts - case referred to Larger Bench: SC (See 'Legal Desk') ICAT marks 20 Years of Excellence with PM e-Drive Dialogue with the industry (See 'Corp Brief') From Rural Needs to Real-World Solutions: RuTAG 2.0 focuses on deepening Technology Impact (See 'Corp Brief') India International Water Week 2026 concludes with Focus on Climate-Resilient Management (See 'Corp Brief') A&C - Period of limitation u/s 34(3) of Arbitration Act must be reckoned from date of disposal of Sec 33 application, regardless of whether such application is ultimately found to be frivolous or sham: HC (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT)

Print

NPPA monitors prices of scheduled & non-scheduled medicines

Published: Jul 30, 2024

By TIOLCorplaws News Service

NEW DELHI, JULY 30, 2024: AS per the provisions of Drugs (Prices Control) Order, 2013 (DPCO, 2013), formulations listed in Schedule-I of the DPCO are defined as scheduled formulation under section 2(1)(zb) of DPCO, 2013. Formulations not included in Schedule-I are defined under Para 2(1)(v) of DPCO, 2013 as non-scheduled formulation. Thus, both schedule and non-schedule drugs are covered under DPCO, 2013. 

As per the extant provisions of DPCO, 2013, the ceiling prices of scheduled medicines are revised annually on the basis of Wholesale Price Index (WPI) (all commodities) for preceding calendar year by National Pharmaceutical Pricing Authority (NPPA), on or before 1st April of every year and is notified by the Government on the 1st day of April every year. The details of price fixed by NPPA are available at NPPA's website i.e. nppaindia.nic.in.  In case of non-scheduled formulation (branded or generic), as per para 20 of DPCO, 2013, no manufacturers can increase Maximum Retail Price (MRP) by more than 10% of MRP during preceding 12 months.  The maximum permissible increase in prices, as per the provisions of DPCO, 2013 for scheduled and non-scheduled drugs may or may not be availed by their respective manufacturers based on commercial considerations and market dynamics.

Under the Drugs and Cosmetics Act, 1945 and Rules thereunder, manufacturers of drugs are required to comply with conditions of manufacturing licence and the requirements of Good Manufacturing Practices (GMP).  As per the Drugs Rules, 1945, the manufacturing, testing, labeling, packaging, storage and distribution are required to be carried out in compliance with the conditions of license including the Good manufacturing practices (GMP) prescribed under the Schedule M of the Drugs Rules, 1945. In case of violation, the Licensing Authority is empowered to take action as per the said Act and Rules.

NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013.  Action is taken against companies, found selling formulations at prices higher than the permissible price, and the overcharged amount is recovered from the company as per the relevant provisions of the DPCO, 2013. During the financial year 2023-24, Rs. 72.73 crore was recovered from the defaulting companies.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in reply to a question today.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.